Metformin reduces the risk of cancer in patients with type 2 diabetes: An analysis based on the Korean National Diabetes Program Cohort

The epidemiological literature suggests that insulin resistance, hyperinsulinemia, and increased levels of insulin-like growth factors place patients with type 2 diabetes mellitus (T2DM) at greater risk of cancer. The association between cancer incidence and the use of antidiabetic medications in pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hae Jin, Lee, SooJin, Chun, Ki Hong, Jeon, Ja Young, Han, Seung Jin, Kim, Dae Jung, Kim, Young Seol, Woo, Jeong-Taek, Nam, Moon-Suk, Baik, Sei Hyun, Ahn, Kyu Jeung, Lee, Kwan Woo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
4300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841986/
https://www.ncbi.nlm.nih.gov/pubmed/29465545
http://dx.doi.org/10.1097/MD.0000000000010036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841986/
https://www.ncbi.nlm.nih.gov/pubmed/29465545
http://dx.doi.org/10.1097/MD.0000000000010036

Ejemplares similares